Menatetrenone


Menatetrenone
Menatetrenone
Systematic (IUPAC) name
2-methyl-3-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthoquinone
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status  ?
Routes Oral
Identifiers
CAS number 863-61-6
ATC code None
PubChem CID 5282367
UNII 27Y876D139 YesY
KEGG D00100 YesY
Synonyms 3-methyl-2-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione
Chemical data
Formula C31H40O2 
Mol. mass 444.648 g/mol
 YesY(what is this?)  (verify)

Menatetrenone (INN), also known as MK4, is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis. It is marketed for the latter indication in Japan by Eisai Co., under the trade name Glakay.

Menatetrenone (MK4) is one of the nine forms of vitamin K2.[1]

See also

References

External links